Intellectual Property India Publishes Patent Application for 'Compositions And Methods For The Treatment Of Neurological Disorders Related To Glucosylceramidase Beta 1 Deficiency' Filed by Voyager Therapeutics, Inc.

MUMBAI, India, Oct. 11 -- Intellectual Property India has published a patent application (202517071012 A) filed by Voyager Therapeutics, Inc., Lexington, U.S.A., on July 25, for 'compositions and methods for the treatment of neurological disorders related to glucosylceramidase beta 1 deficiency.'

Inventor(s) include Chung, Hiu Yan; Knoll, Elisabeth; and Carter, Todd.

The application for the patent was published on Oct. 10, under issue no. 41/2025.

According to the abstract released by the Intellectual Property India: "The disclosure relates to compositions and methods for altering, e.g., enhancing, the expression of GCase proteins, whether in vitro and/or in vivo. Such compositions include delivery of an adeno-associated viral (AAV) part...